Introduction
============

Rotavirus infection is a major cause of severe diarrhea in infants and young children globally, and can be fatal ([@ref1]--[@ref3]). The global burden of rotavirus is estimated at 110 million cases and 520,000 deaths among young children each year. Overall diarrhea is the second leading cause of death in children under age five and approximately 80% of diarrheal deaths in poor regions are caused by rotavirus ([@ref4]--[@ref6]). Children under two-years old are the most vulnerable to rotavirus and have higher case-fatality rates ([@ref7], [@ref8]). Contrary to many bacterial diarrhea infections, rotavirus peaks during cool or humid weather ([@ref9]). Dehydration is the primary driver of fatality due to rotavirus and breast feeding and oral rehydration therapy can reduce the case-fatality rates ([@ref2], [@ref10]). Two primary prevention strategies are used for rotavirus, improved hygiene, sanitation, and vaccination. The rotavirus vaccine is highly effective; approximately 86% yet many countries, which have the highest burden of rotavirus vaccine, have still not introduced it into their childhood immunization schedule ([@ref11]). Rotaviral infection is still increasing, accounting for 39% of childhood hospitalizations for diarrhea up from 22% 20 years ago ([@ref12]). In developing countries, rotavirus leads to a high number of deaths and causes a significant economic burden on the heath sector ([@ref13]). In Libya, most health service sectors are publicly owned and provide preventive, curative and rehabilitation services to all citizens free of charge. The Ministry of Health is responsible for all health programs including planning, evaluation, health education, medical equipment, medical services, drugs and administration and finance. Historically national surveillance data demonstrated that rotavirus cases accounted for 24%-45% of diarrheal cases between 1980 and 2009 ([@ref14], [@ref15]). Accurate data became unavailable, however, after the revolution in 2011 disrupted routine surveillance.

To determine current estimates of the burden of rotavirus this study collected information on rotaviral infection in children aged 5 years and below in a northwestern region of Libya.

Methods and Materials
=====================

Study Design and Study Population
---------------------------------

A prospective cross-sectional study was conducted from August 2012 to April 2013 (9 months) in all three public hospitals in northwestern Libya; Zliten, Khoms and Mslata public hospitals. These hospitals serve approximately 57,180 children aged 5 years and below, being 8% of total children (705, 190) aged 5 years and below in Libya. There are no private hospitals in this region while private and public clinics do not provide treatment services as intravenous fluid (IVF) for diarrhea. Children 5 years old and below who presented with diarrhea at the outpatient clinics or who were admitted to the pediatric wards were eligible for inclusion. Demographic, risk factor and symptomology data were collected.

Case Definition
---------------

Patients described in this study were children aged 5 years and below with diarrhea, with or without other symptoms such as fever, vomiting or dehydration ([@ref16], [@ref17]), both outpatient and hospitalized cases were included. The standard definition of diarrhea was used; three or more instances of liquid stool in a day ([@ref18]).

Data Collection
---------------

Laboratory, clinical and risk factor data were collected.

Laboratory data: Stool samples were collected by a nurse. Since rotavirus testing was not done routinely in the three hospitals, the stool samples were tested by the laboratory of the National Center for Diseases Control (NCDC) located in Tripoli and Zliten, the only facility in Libya with this capacity. Stool specimens were stored at approximately -20°C and tested within one week after taking the samples. An enzyme immunoassay (ProSpect Rotavirus Test, Oxoid Ltd, UK) was used to confirm the infection of rotavirus (Group A). "The ProSpecT™ Rotavirus test is a qualitative enzyme immunoassay for the detection of rotavirus (Group A) in human faecal samples as an aid in the diagnosis of acute gastroenteritis. The test utilises a polyclonal antibody to detect group specific proteins, including the major inner capsid protein (VP6), present in Group A rota-viruses" ([@ref19]). This test was appropriate since human rotavirus serotypes for group A are a main cause of diarrhea among young children worldwide ([@ref20], [@ref21]). Risk factor and clinical data: Information was collected on the characteristics of diarrhoea and the proportion rotavirus infection among the diarrhea cases was determined. Demographic data were collected on patient status, gender, place of residence, date of visit/ admission. Factors associated with rotavirus infection such as the duration of symptoms, fever, vomiting and severity of dehydration, the type of rehydration treatment, outcome of treatment and mortality were identified from the patient's record.

Statistical Analysis
--------------------

The data was entered into SPSS version 16. Comparisons were made between characteristics of the rotavirus and non-rotavirus positive cases using the chi-square test, with *P* values \<0.05 considered statistically significant. To determine the association between risk factors/ clinical factors and rotavirus infection other tests including the Mann---Whitney test and multiple logistic regression were performed. Seasonality of rotavirus infections was examined by determining the relative percentage of diarrheal cases attributed to rota-virus by month. Approximate yearly incidence of rotavirus diarrhea in the study area was determined per 100,000 children aged five years and below based on the catchment population of 2012 in study districts (57,180 children aged 5 years and below). The missing rotavirus cases from May to July were projected using data from NCDC's reports during the period from 2007 to 2009. We assumed that the seasonal pattern was similar for rotavirus across Libya and applied the relative average percentage of national-level cases detected in May, June and July from the NCDC's reports to the regional data.

Ethics
------

Oral consent was obtained from patient's parents after informing them on the purpose of the study. This study was approved by the University of Malaya Medical Ethics Committee (IRP - 908.6) in Malaysia, NCDC in Libya and managements of the study hospitals.

Results
=======

Proportion of Diarrhoea accounted for by Rotavirus
--------------------------------------------------

A total of 545 diarrheal cases were observed during the study period. Of these, 135 (25%) were outpatients and 410 (75%) were admitted cases. Rotavirus accounted for a significantly higher proportion of diarrheal cases than other infectious agents (311 (57%) vs. 243 (43%), *P*=0.001) Rota-virus positive cases were more common in admitted patients 58% (239/410), than in outpatient, 53% (72/135), *P*=0.313. No difference was seen in diarrhea attributed to rotavirus between males and females (57% (179/315) vs. 57% (132/230); *P*=0.895), or urban and rural areas (56% (70/124) vs. 57% (241/421), *P*=0.876). Rotavirus comprised nearly all diarrheal illnesses in children under two years of age but only a small percentage in children over age 2 (86% (266/311) vs. (14% (45/311), *P*=0.031).

Seasonality of Rotavirus Diarrhea
---------------------------------

The distribution of cases attributable to rotavirus fluctuated greatly over the course of the study period. Almost all rotavirus cases (n=283, 91%) were diagnosed in the winter months (Dec 2012--- Mar 2013).

Only n=8, 3% were diagnosed in the summer months (Aug 2012 --- Nov 2012). The proportion of diarrheal illness attributed to rotavirus was lowest in October 2013 (n=1, 0.3%) and highest in February (n=109, 76%) ([Table 1](#T1){ref-type="table"}).

###### 

Seasonal distribution of diarrhea aged 5 years and below

  Season   Month       n of tested   Positive-Rotavirus   \%
  -------- ----------- ------------- -------------------- -----
  Summer                                                  
           Aug 2012    12            1                    6
           Sept 2012   30            3                    10
           Oct 2012    31            1                    0.3
           Nov 2012    21            3                    14
  Winter                                                  
           Dec 2012    61            34                   56
           Jan 2013    87            63                   72
           Feb 2013    143           109                  76
           Mar 2013    105           77                   73
  Spring                                                  
           Apr 2013    55            20                   36
  Total    545         311           57                   

Significant level is

P

\<0.05

Factors Associated with Rotavirus Infection and Mortality
---------------------------------------------------------

The duration of symptoms in most rotavirus cases (n=255, 82%) was below one week. Fever was found in 65% of rotavirus cases (n=203), and vomiting in 98% of rotavirus cases (n=304). Severe, moderate and non-dehydration were found in 31% (n=97), 66% (n=205) and 3% (n=9) of rotavirus patients, respectively (*P*=0.519). 99% (n=309) of positive rotavirus patients were treated by intravenous fluid (IVF) with only two positive rotavirus cases treated by solely with oral rehydration therapy (ORT) (n=2, 1%) ([Table 2](#T2){ref-type="table"}). Death related to diarrhea or rotavirus infection was not observed during the period of the study. Predictors of rotavirus diarrhea vs. other causes of diarrhea included presentation during cool months (OR=; *P*=4.383), presence of vomiting (OR=; *P*=8.420) and patient with severe dehydration (OR=; *P*=5.389) ([Table 3](#T3){ref-type="table"}).

###### 

Factors associated with diarrhea among patients

  Demographic Profiles and Characteristics   Rotavirus Positive (n = 311)   Rotavirus Negative (n = 234)               
  ------------------------------------------ ------------------------------ ------------------------------ ----- ----- ----
  Duration of Symptoms                                                                                                 
                                             \< 1 Week                      255                            82    185   79
                                             8 Days and Above               56                             18    49    21
  Fever                                      203                            65                             163   70    
  Vomiting                                   304                            98                             196   84    
  Dehydration                                302                            97                             204   87    
  Dehydration Degree                                                                                                   
                                             Severe                         97                             31    60    26
                                             Moderate                       205                            66    144   62
                                             None                           9                              3     30    13
  Rehydration Treatment                                                                                                
                                             ORT                            2                              1     17    7
                                             IVF                            309                            99    217   93
  Outcome of Treatment                                                                                                 
                                             Improved                       196                            63    74    32
                                             Complicated                    3                              1     4     2
                                             Unknown                        112                            36    156   67

###### 

Factors associated with rotavirus diarrhoea in the study

  Variable        Crude OR^a^ (95%Cl)    Adjusted OR^b^ (95%Cl)   Wald statistics^b^ (df)   *P*-value^b^
  --------------- ---------------------- ------------------------ ------------------------- --------------
  Season                                                                                    
       Summer     0.163 (0.066-0.404)    0.186 (0.073-0.471)      12.851 (1)                0.000
       Winter     4.383 (2.427-7.915)    4.282 (2.335-7.853)      22.094 (1)                0.000
       Spring     1                      1                                                  
  Vomiting                                                                                  
       Yes        8.420 (3.687-19.230)   6.041 (2.407-15.162)     14.678 (1)                0.000
       No         1                      1                                                  
  Dehydration                                                                               
       Severe     5.389 (2.394-12.132)   3.860 (1.496-9.959)      7.801 (1)                 0.005
       Moderate   4.745 (2.187-10.298)   2.713 (1.103-6.675)      4.725 (1)                 0.030
       None       1                      1                                                  

a

Simple logistic regression,

b

Multiple logistic regression

Incidence of Rotavirus Diarrhea in the Study Area
-------------------------------------------------

The unadjusted incidence of rotavirus requiring treatment was 544 per 100,000 per nine months. The projected annual number of rotavirus was 366 cases. Applying this adjusted number of rota-virus diarrhea cases for 12 months requiring treatment in this study, the incidence rate of rotavirus diarrhea for children 5 years old and under the catchment population of 2012 in the studied hospitals (57,180 children aged 5 years and below) was estimated to be 640 per 100,000 per year among children aged 5 years and below (range: 589---696 per 100,000 children aged 5 years and below).

Discussion
==========

This study aimed to determine the burden of rota-virus infection posed to the north-western region of Libya. Results indicate that rotavirus infection among children under 5 years is high, constituting over half of diarrheal illnesses and poses a significant disease burden to the northwestern region of Libya. The rate of diarrhea cases attributed to rotavirus infection determined in the current study was comparable to reports at national and local levels. Official reports of Libya from 2007 to 2009 ([@ref15], [@ref22], [@ref23]) reported that on average rotavirus accounted for 44% of diarrheal illnesses similar to reports from 1980 to 2009 which indicated rota-virus accounted for 24% to 45% of all diarrhea illness in children under 5 years. ([@ref10], [@ref14], [@ref24]--[@ref26]). Also, in Tripoli, the capital of Libya, rotavirus also constituted a lower amount (33%) from September 2008 to May 2009 (9 months) ([@ref26]).

Given the severe nature of dehydration that often occurs in rotavirus patients, it was not surprising that rotavirus accounted for a higher percentage of diarrheal illness in admitted vs. outpatient cases. This has been found in other studies of rotavirus in Libya ([@ref24], [@ref26]). As severe illness from rotavirus is most common in children under two, it was not surprising that our study also demonstrated this trend ([@ref15], [@ref22]-[@ref24], [@ref26]). As the hospitals in the study site are located in more rural populations, most of the cases were from rural areas (77%).

Global estimates of rotavirus incidence prior to the implementation of wide-scale vaccination programs varied widely and were not necessarily correlated with level of development ([@ref27]). In Australia rates were higher than in Libya (750 cases per 100,000 children under 5 ([@ref28]), but in Europe rates were lower ([@ref29], [@ref30]). Prior to adoption of vaccination programs for rotavirus, about 45% of countries in the world had the incidence of rota-virus of about more than 200 cases per 100,000 children aged 5 years and below ([@ref31]). Compared to other countries in the Middle East and North Africa region, most countries, with the exception of Oman and Iran, had a lower incidence of rota-virus than what was found in northwestern Libya ([@ref14]). Libya, therefore, is considered a high rota-virus incidence country. It is difficult to make direct comparisons to other countries as part of the high disease incidence in Libya may be attributed to easy access to health services and thus capture of a higher proportion of rotavirus infections than in countries with less available health care.

No deaths were attributed to rotavirus infection in the study population; however, WHO estimated the mortality rate in Libya was 14 per 100,000 in children under five from 1999 to 2009. This is lower than some countries in the region where mortality due to rotavirus ranges from 0 to 112 per 100,000 children aged 5 years and below ([@ref14]). Comparisons that are more global indicate that mortality due to rotavirus infection in Libya is low compared to some African and South American countries ([@ref32]). It is likely that Libya's free and accessible health care facilitates effective treatment for diarrhea in children with diarrhea. Indeed, mortality due to rotavirus is very low in other countries where health care access is high, including the United States and Europe ([@ref27]).

Globally, the rotavirus infection increased from 22% to 39% for the period of 1986 to 2004, which was similar to the increase of the rotavirus detection in this study ([@ref13], [@ref33]). Since that time, rotavirus has declined in countries, which have introduced the vaccine ([@ref34], [@ref35]). Based on the rate of rotavirus infection during the study period, the incidence rate of rotavirus diarrhea was 640/100,000 of children aged 5 years and below. This incidence is higher than the reported national incidence from 2009 published by the NCDC in Libya of 449 cases per 100,000 of children aged 5 years and below. The NCDC's report indicated that rotavirus infection was rising steadily and study results suggest this may be the case. However, there may also be geographic differences in rotavirus transmission that could be an alternative explanation for the higher incidence reported out of the hospitals in northwestern Libya.

Several limitations were encountered during data collection. The incidence of rotavirus infection was obtained by estimating the rate of rotavirus among children aged 5 years and below who presented with diarrhea at all hospitals which serve of the north-western region of Libya. Ideally, incidence rates should be calculated for a period of one year, covering all twelve months in a year. However, due to insecurity after the revolution, data collection was lapsed in the months of May to July. These three months were not included since the study had to be discontinued due to expired rotavirus kit in the laboratory after only nine months' of data collection. Because of the complex and time-consuming procedures needed to import new kits under the auspices of the Ministry of Health as well as instability after the revolution. Therefore, we applied the average proportion of reported cases occurring in May, June and July from the NCDC report to obtain an estimate of annual incidence. Given the seasonality of rota-virus ([@ref36]) is likely a better approximation of yearly incidence than either averaging the nine months of available data to create an estimated incidence or assuming that there were no cases detected during May, June and July. However, the resulting rate was higher than that in previous reports from NCDC and may be an over-estimate.

This study has indicated that rotavirus is a significant cause of diarrhea or diarrhea and is still in widespread, indicating that preventive program should be taken up or straightened. The introduction of rotavirus vaccine with a high coverage rate into the national immunization program could reduce the transmission of rotavirus infection among infants and young children as has been successfully in many countries. The cost-effectiveness of implementation should be conducted carefully as it has been shown that incorporating routine vaccination is more cost-effective in high mortality countries. Given the low mortality rate in Libya, the cost-benefit must be determined before broad-scale implementation is recommended ([@ref37]).

Conclusion
==========

The significant burden of rotavirus diarrhea was estimated among children aged 5 years and below in Libya. The study demonstrated that the incidence of rotavirus diarrhea was high among children 5 years old and below. The disease burden could be reduced by enhancing health education such as proper hygiene care. Further exploration of the cost-benefit of vaccination implementation is warranted given the high burden of rotavirus infection present in Libya.
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